25 XP   0   0   10

Pulse Biosciences Inc
Buy, Hold or Sell?

Let's analyse Pulse Biosciences Inc together

PenkeI guess you are interested in Pulse Biosciences Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Pulse Biosciences Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Pulse Biosciences Inc

I send you an email if I find something interesting about Pulse Biosciences Inc.

Quick analysis of Pulse Biosciences Inc (30 sec.)










What can you expect buying and holding a share of Pulse Biosciences Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.01
When do you have the money?
1 year
How often do you get paid?
5.4%

What is your share worth?

Current worth
$0.81
Expected worth in 1 year
$1.65
How sure are you?
27.0%

+ What do you gain per year?

Total Gains per Share
$0.85
Return On Investment
11.9%

For what price can you sell your share?

Current Price per Share
$7.19
Expected price per share
$4.7 - $7.79
How sure are you?
50%

1. Valuation of Pulse Biosciences Inc (5 min.)




Live pricePrice per Share (EOD)

$7.19

Intrinsic Value Per Share

$-3.86 - $-4.29

Total Value Per Share

$-3.05 - $-3.48

2. Growth of Pulse Biosciences Inc (5 min.)




Is Pulse Biosciences Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$44.3m$12m$24.5m67.1%

How much money is Pulse Biosciences Inc making?

Current yearPrevious yearGrowGrow %
Making money-$10.6m-$14.6m$3.9m37.0%
Net Profit Margin0.0%23,178.2%--

How much money comes from the company's main activities?

3. Financial Health of Pulse Biosciences Inc (5 min.)




4. Comparing to competitors in the Medical Instruments & Supplies industry (5 min.)




  Industry Rankings (Medical Instruments & Supplies)  


Richest
#125 / 171

Most Revenue
#170 / 171

Most Profit
#147 / 171

Most Efficient
#108 / 171

What can you expect buying and holding a share of Pulse Biosciences Inc? (5 min.)

Welcome investor! Pulse Biosciences Inc's management wants to use your money to grow the business. In return you get a share of Pulse Biosciences Inc.

What can you expect buying and holding a share of Pulse Biosciences Inc?

First you should know what it really means to hold a share of Pulse Biosciences Inc. And how you can make/lose money.

Speculation

The Price per Share of Pulse Biosciences Inc is $7.19. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Pulse Biosciences Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Pulse Biosciences Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.81. Based on the TTM, the Book Value Change Per Share is $0.21 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.17 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Pulse Biosciences Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.22-3.0%-0.19-2.7%-0.27-3.7%-0.24-3.3%-0.18-2.5%
Usd Book Value Change Per Share-0.14-2.0%0.212.9%-0.17-2.4%-0.02-0.3%0.020.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.050.7%0.030.4%
Usd Total Gains Per Share-0.14-2.0%0.213.0%-0.17-2.4%0.030.4%0.050.7%
Usd Price Per Share12.24-6.71-2.87-11.38-10.71-
Price to Earnings Ratio-14.12--8.52--2.75--12.02--16.16-
Price-to-Total Gains Ratio-86.60--32.73--2.81--65.85--74.15-
Price to Book Ratio15.20-2.16--7.73-14.47-15.46-
Price-to-Total Gains Ratio-86.60--32.73--2.81--65.85--74.15-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share7.19
Number of shares139
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.05
Usd Book Value Change Per Share0.21-0.02
Usd Total Gains Per Share0.210.03
Gains per Quarter (139 shares)29.714.24
Gains per Year (139 shares)118.8416.96
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1111810928-117
2223522856-2224
3435334784-3341
45470466112-4458
56588585140-5575
67706704168-6792
79823823196-78109
810941942224-89126
91110591061252-100143
101211761180281-111160

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.037.00.00.0%0.037.00.00.0%
Book Value Change Per Share1.03.00.025.0%3.09.00.025.0%4.016.00.020.0%9.025.03.024.3%9.025.03.024.3%
Dividend per Share1.00.03.025.0%2.00.010.016.7%2.00.018.010.0%2.00.035.05.4%2.00.035.05.4%
Total Gains per Share1.03.00.025.0%4.08.00.033.3%5.015.00.025.0%10.024.03.027.0%10.024.03.027.0%

Fundamentals of Pulse Biosciences Inc

About Pulse Biosciences Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. The company was incorporated in 2014 and is headquartered in Hayward, California.

Fundamental data was last updated by Penke on 2024-04-12 15:15:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Pulse Biosciences Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Pulse Biosciences Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Pulse Biosciences Inc to the Medical Instruments & Supplies industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Pulse Biosciences Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY23,178.2%-23,178.2%
TTM-5Y3,816.8%-3,816.8%
5Y3,816.8%10Y-433.9%+4,250.8%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-6.3%-6.3%
TTM-6.5%-6.5%
YOY23,178.2%8.2%+23,170.0%
5Y3,816.8%7.3%+3,809.5%
10Y-433.9%7.6%-441.5%
1.1.2. Return on Assets

Shows how efficient Pulse Biosciences Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Pulse Biosciences Inc to the Medical Instruments & Supplies industry mean.
  • -19.6% Return on Assets means that Pulse Biosciences Inc generated $-0.20 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Pulse Biosciences Inc:

  • The MRQ is -19.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -15.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-19.6%TTM-15.9%-3.7%
TTM-15.9%YOY-27.6%+11.7%
TTM-15.9%5Y-23.7%+7.9%
5Y-23.7%10Y-18.6%-5.1%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-19.6%1.3%-20.9%
TTM-15.9%1.4%-17.3%
YOY-27.6%2.0%-29.6%
5Y-23.7%2.1%-25.8%
10Y-18.6%2.0%-20.6%
1.1.3. Return on Equity

Shows how efficient Pulse Biosciences Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Pulse Biosciences Inc to the Medical Instruments & Supplies industry mean.
  • -26.9% Return on Equity means Pulse Biosciences Inc generated $-0.27 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Pulse Biosciences Inc:

  • The MRQ is -26.9%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -15.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-26.9%TTM-15.9%-11.0%
TTM-15.9%YOY-108.6%+92.7%
TTM-15.9%5Y-49.1%+33.2%
5Y-49.1%10Y-32.9%-16.2%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-26.9%2.6%-29.5%
TTM-15.9%2.9%-18.8%
YOY-108.6%3.9%-112.5%
5Y-49.1%3.8%-52.9%
10Y-32.9%3.9%-36.8%

1.2. Operating Efficiency of Pulse Biosciences Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Pulse Biosciences Inc is operating .

  • Measures how much profit Pulse Biosciences Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Pulse Biosciences Inc to the Medical Instruments & Supplies industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Pulse Biosciences Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY22,930.3%-22,930.3%
TTM-5Y3,765.4%-3,765.4%
5Y3,765.4%10Y-469.9%+4,235.2%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.9%-7.9%
TTM-7.5%-7.5%
YOY22,930.3%11.4%+22,918.9%
5Y3,765.4%10.2%+3,755.2%
10Y-469.9%10.7%-480.6%
1.2.2. Operating Ratio

Measures how efficient Pulse Biosciences Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Pulse Biosciences Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-219.220+219.220
TTM-5Y-35.554+35.554
5Y-35.55410Y7.589-43.143
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.133-1.133
TTM-1.124-1.124
YOY-219.2201.105-220.325
5Y-35.5541.097-36.651
10Y7.5891.056+6.533

1.3. Liquidity of Pulse Biosciences Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Pulse Biosciences Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A Current Ratio of 6.76 means the company has $6.76 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Pulse Biosciences Inc:

  • The MRQ is 6.757. The company is very able to pay all its short-term debts. +2
  • The TTM is 8.701. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ6.757TTM8.701-1.943
TTM8.701YOY6.547+2.154
TTM8.7015Y7.481+1.220
5Y7.48110Y10.351-2.870
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ6.7572.320+4.437
TTM8.7012.382+6.319
YOY6.5472.575+3.972
5Y7.4812.627+4.854
10Y10.3512.623+7.728
1.3.2. Quick Ratio

Measures if Pulse Biosciences Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Pulse Biosciences Inc to the Medical Instruments & Supplies industry mean.
  • A Quick Ratio of 6.61 means the company can pay off $6.61 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Pulse Biosciences Inc:

  • The MRQ is 6.614. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 8.537. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ6.614TTM8.537-1.923
TTM8.537YOY5.872+2.664
TTM8.5375Y9.179-0.642
5Y9.17910Y13.092-3.913
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ6.6141.111+5.503
TTM8.5371.159+7.378
YOY5.8721.286+4.586
5Y9.1791.423+7.756
10Y13.0921.521+11.571

1.4. Solvency of Pulse Biosciences Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Pulse Biosciences Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Pulse Biosciences Inc to Medical Instruments & Supplies industry mean.
  • A Debt to Asset Ratio of 0.27 means that Pulse Biosciences Inc assets are financed with 27.0% credit (debt) and the remaining percentage (100% - 27.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Pulse Biosciences Inc:

  • The MRQ is 0.270. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.456. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.270TTM0.456-0.185
TTM0.456YOY0.714-0.258
TTM0.4565Y0.416+0.040
5Y0.41610Y0.261+0.155
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2700.351-0.081
TTM0.4560.357+0.099
YOY0.7140.357+0.357
5Y0.4160.359+0.057
10Y0.2610.371-0.110
1.4.2. Debt to Equity Ratio

Measures if Pulse Biosciences Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Pulse Biosciences Inc to the Medical Instruments & Supplies industry mean.
  • A Debt to Equity ratio of 37.1% means that company has $0.37 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Pulse Biosciences Inc:

  • The MRQ is 0.371. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.218. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.371TTM0.218+0.153
TTM0.218YOY3.696-3.478
TTM0.2185Y1.141-0.923
5Y1.14110Y0.656+0.484
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3710.541-0.170
TTM0.2180.559-0.341
YOY3.6960.545+3.151
5Y1.1410.610+0.531
10Y0.6560.669-0.013

2. Market Valuation of Pulse Biosciences Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Pulse Biosciences Inc generates.

  • Above 15 is considered overpriced but always compare Pulse Biosciences Inc to the Medical Instruments & Supplies industry mean.
  • A PE ratio of -14.12 means the investor is paying $-14.12 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Pulse Biosciences Inc:

  • The EOD is -8.297. Based on the earnings, the company is expensive. -2
  • The MRQ is -14.124. Based on the earnings, the company is expensive. -2
  • The TTM is -8.522. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-8.297MRQ-14.124+5.827
MRQ-14.124TTM-8.522-5.602
TTM-8.522YOY-2.746-5.776
TTM-8.5225Y-12.019+3.497
5Y-12.01910Y-16.163+4.144
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD-8.29715.252-23.549
MRQ-14.12417.745-31.869
TTM-8.52218.883-27.405
YOY-2.74622.890-25.636
5Y-12.01921.018-33.037
10Y-16.16326.090-42.253
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Pulse Biosciences Inc:

  • The EOD is -14.519. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -24.717. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -11.935. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-14.519MRQ-24.717+10.198
MRQ-24.717TTM-11.935-12.783
TTM-11.935YOY-3.396-8.539
TTM-11.9355Y-15.954+4.019
5Y-15.95410Y-32.871+16.917
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD-14.51910.158-24.677
MRQ-24.71710.068-34.785
TTM-11.9351.502-13.437
YOY-3.3964.281-7.677
5Y-15.9547.622-23.576
10Y-32.8710.247-33.118
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Pulse Biosciences Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A PB ratio of 15.20 means the investor is paying $15.20 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Pulse Biosciences Inc:

  • The EOD is 8.928. Based on the equity, the company is overpriced. -1
  • The MRQ is 15.198. Based on the equity, the company is expensive. -2
  • The TTM is 2.163. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD8.928MRQ15.198-6.270
MRQ15.198TTM2.163+13.035
TTM2.163YOY-7.732+9.896
TTM2.1635Y14.475-12.312
5Y14.47510Y15.463-0.988
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD8.9282.434+6.494
MRQ15.1982.782+12.416
TTM2.1632.767-0.604
YOY-7.7323.290-11.022
5Y14.4753.530+10.945
10Y15.4634.227+11.236
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Pulse Biosciences Inc.

3.1. Institutions holding Pulse Biosciences Inc

Institutions are holding 8.085% of the shares of Pulse Biosciences Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31BlackRock Inc1.94580.0003107173610530710.8965
2023-12-31Bank of America Corp1.45490.00180134193711.1833
2023-12-31Vanguard Group Inc1.19460.000265798531651992.6941
2023-12-31Geode Capital Management, LLC0.68860.0005379259251747.1096
2023-12-31State Street Corporation0.56190.0002309520252848.8954
2023-12-31Hovey Youngman Associates Inc0.47130.4029259620-15140-5.5103
2023-12-31Northern Trust Corp0.33340.000418366548772.7278
2023-12-31Spotlight Asset Group, Inc.0.13090.26357209000
2023-12-31Bank of New York Mellon Corp0.08370.000146129-5826-11.2136
2023-12-31Morgan Stanley - Brokerage Accounts0.08250.0001454381904472.1528
2023-12-31Advisor Group Holdings, Inc.0.08020.00144195-15212-25.6064
2023-12-31Charles Schwab Investment Management Inc0.07930.00014369500
2023-12-31SIMPLEX TRADING, LLC0.06230.000334293342930
2023-12-31Westside Investment Management, Inc.0.0620.10734175-24583-41.8377
2023-12-31JANE STREET GROUP, LLC0.0610.000133578335780
2023-12-31CWM Advisors, LLC0.05690.042231319313190
2023-12-31Susquehanna International Group, LLP0.050.000127535275350
2023-12-31TIAA Trust National Association0.04960.00112729800
2023-12-31Marshall Wace Asset Management Ltd0.04820.000626532265320
2023-12-31Nuveen Asset Management, LLC0.04790.000126372360715.8445
Total 7.5450.82184155775+601679+14.5%

3.2. Funds holding Pulse Biosciences Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv0.86740.000347901700
2024-03-28iShares Russell 2000 ETF0.71320.00523938551890.048
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.46580.002525724400
2024-01-31Fidelity Small Cap Index0.29670.005916384124601.5243
2024-03-28iShares Russell 2000 Value ETF0.20590.0079113716-72-0.0633
2024-02-29State St Russell Sm/Mid Cp® Indx NL Cl C0.19230.002510620030002.907
2024-02-29Fidelity Extended Market Index0.17720.002597878-474-0.4819
2024-03-31State St Russell Sm Cap® Indx SL Cl I0.10680.00535900000
2024-02-29Vanguard Russell 2000 ETF0.10530.0065813246288.6498
2023-12-31NT R2000 Index Fund - NL0.07860.0073434052080.4815
2024-02-29Fidelity Nasdaq Composite Index0.06690.00243694000
2024-02-29Schwab Small Cap Index0.06690.00623692200
2023-09-30BlackRock Extended Mkt Composite0.06610.001365062830.7813
2024-03-28iShares Russell 2000 Growth ETF0.06540.002736092-42-0.1162
2024-03-28iShares Micro-Cap ETF0.06330.03313493800
2023-12-31NT R2000 Index Fund - DC - NL - 20.06190.007334182320.0937
2023-12-31NT R2000 Value Index Fund - NL0.05710.0102315261470.4685
2024-03-31BlackRock Extended Equity Market K0.05690.001931444110.035
2024-02-29Fidelity Total Market Index0.05420.00032991500
2024-02-29iShares Russell 2000 Small-Cap Idx Instl0.05410.00642986000
Total 3.8220.11692110613+10370+0.5%

3.3. Insider Transactions

Insiders are holding 70.556% of the shares of Pulse Biosciences Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-12-11Robert W DugganBUY901189.36
2023-12-08Robert W DugganBUY1166569.54
2023-12-06Robert W DugganBUY828139.06
2023-12-04Robert W DugganBUY2700010.38
2023-11-30Robert W DugganBUY1529449.06
2023-11-28Robert W DugganBUY1243978.98
2023-11-17Robert W DugganBUY202416.1
2023-11-16Kevin Patrick DanahyBUY53936.52
2023-11-15Mitchell E LevinsonBUY42615.87
2023-05-09Robert W DugganBUY100229376.51

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Pulse Biosciences Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.1410.212-167%-0.172+22%-0.020-86%0.022-749%
Book Value Per Share--0.8050.664+21%0.219+268%0.597+35%0.564+43%
Current Ratio--6.7578.701-22%6.547+3%7.481-10%10.351-35%
Debt To Asset Ratio--0.2700.456-41%0.714-62%0.416-35%0.261+4%
Debt To Equity Ratio--0.3710.218+70%3.696-90%1.141-68%0.656-44%
Dividend Per Share---0.002-100%-0%0.050-100%0.027-100%
Eps---0.217-0.192-12%-0.269+24%-0.238+10%-0.180-17%
Free Cash Flow Per Share---0.124-0.150+22%-0.215+74%-0.187+51%-0.124+0%
Free Cash Flow To Equity Per Share---0.109-0.076-30%0.148-174%-0.014-87%0.056-295%
Gross Profit Margin--1.0251.006+2%1.195-14%1.087-6%1.047-2%
Intrinsic Value_10Y_max---4.286--------
Intrinsic Value_10Y_min---3.856--------
Intrinsic Value_1Y_max---0.762--------
Intrinsic Value_1Y_min---0.749--------
Intrinsic Value_3Y_max---2.037--------
Intrinsic Value_3Y_min---1.950--------
Intrinsic Value_5Y_max---3.006--------
Intrinsic Value_5Y_min---2.812--------
Market Cap396028795.000-70%674185320.000369314752.500+83%157805632.500+327%627036412.000+8%590150340.946+14%
Net Profit Margin----0%231.782-100%38.168-100%-4.3390%
Operating Margin----0%229.303-100%37.654-100%-4.6990%
Operating Ratio----0%-219.2200%-35.5540%7.589-100%
Pb Ratio8.928-70%15.1982.163+603%-7.732+151%14.475+5%15.463-2%
Pe Ratio-8.297+41%-14.124-8.522-40%-2.746-81%-12.019-15%-16.163+14%
Price Per Share7.190-70%12.2406.705+83%2.865+327%11.384+8%10.714+14%
Price To Free Cash Flow Ratio-14.519+41%-24.717-11.935-52%-3.396-86%-15.954-35%-32.871+33%
Price To Total Gains Ratio-50.871+41%-86.601-32.732-62%-2.808-97%-65.852-24%-74.153-14%
Quick Ratio--6.6148.537-23%5.872+13%9.179-28%13.092-49%
Return On Assets---0.196-0.159-19%-0.276+41%-0.237+21%-0.186-5%
Return On Equity---0.269-0.159-41%-1.086+304%-0.491+83%-0.329+22%
Total Gains Per Share---0.1410.214-166%-0.172+22%0.031-563%0.049-388%
Usd Book Value--44360001.00036584250.250+21%12038000.000+268%32905000.050+35%31076629.216+43%
Usd Book Value Change Per Share---0.1410.212-167%-0.172+22%-0.020-86%0.022-749%
Usd Book Value Per Share--0.8050.664+21%0.219+268%0.597+35%0.564+43%
Usd Dividend Per Share---0.002-100%-0%0.050-100%0.027-100%
Usd Eps---0.217-0.192-12%-0.269+24%-0.238+10%-0.180-17%
Usd Free Cash Flow---6819000.000-8289000.000+22%-11853500.000+74%-10285150.000+51%-6831210.757+0%
Usd Free Cash Flow Per Share---0.124-0.150+22%-0.215+74%-0.187+51%-0.124+0%
Usd Free Cash Flow To Equity Per Share---0.109-0.076-30%0.148-174%-0.014-87%0.056-295%
Usd Market Cap396028795.000-70%674185320.000369314752.500+83%157805632.500+327%627036412.000+8%590150340.946+14%
Usd Price Per Share7.190-70%12.2406.705+83%2.865+327%11.384+8%10.714+14%
Usd Profit---11933000.000-10672000.000-11%-14618250.000+23%-13082150.000+10%-9123220.000-24%
Usd Revenue----0%175000.000-100%111600.000-100%62297.297-100%
Usd Total Gains Per Share---0.1410.214-166%-0.172+22%0.031-563%0.049-388%
 EOD+3 -5MRQTTM+13 -19YOY+24 -95Y+18 -1710Y+13 -21

4.2. Fundamental Score

Let's check the fundamental score of Pulse Biosciences Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-8.297
Price to Book Ratio (EOD)Between0-18.928
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than16.614
Current Ratio (MRQ)Greater than16.757
Debt to Asset Ratio (MRQ)Less than10.270
Debt to Equity Ratio (MRQ)Less than10.371
Return on Equity (MRQ)Greater than0.15-0.269
Return on Assets (MRQ)Greater than0.05-0.196
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Pulse Biosciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5035.424
Ma 20Greater thanMa 507.811
Ma 50Greater thanMa 1008.854
Ma 100Greater thanMa 2009.231
OpenGreater thanClose7.260
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Long-term Assets Other  365036503650365-1,886-1,521



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets60,804
Total Liabilities16,444
Total Stockholder Equity44,360
 As reported
Total Liabilities 16,444
Total Stockholder Equity+ 44,360
Total Assets = 60,804

Assets

Total Assets60,804
Total Current Assets45,328
Long-term Assets15,476
Total Current Assets
Cash And Cash Equivalents 44,365
Other Current Assets 963
Total Current Assets  (as reported)45,328
Total Current Assets  (calculated)45,328
+/-0
Long-term Assets
Property Plant Equipment 8,784
Goodwill 2,791
Intangible Assets 1,886
Long-term Assets  (as reported)15,476
Long-term Assets  (calculated)13,461
+/- 2,015

Liabilities & Shareholders' Equity

Total Current Liabilities6,708
Long-term Liabilities9,736
Total Stockholder Equity44,360
Total Current Liabilities
Short-term Debt 1,058
Accounts payable 1,836
Other Current Liabilities 3,814
Total Current Liabilities  (as reported)6,708
Total Current Liabilities  (calculated)6,708
+/-0
Long-term Liabilities
Capital Lease Obligations 9,144
Long-term Liabilities  (as reported)9,736
Long-term Liabilities  (calculated)9,144
+/- 592
Total Stockholder Equity
Common Stock55
Retained Earnings -336,915
Other Stockholders Equity 381,220
Total Stockholder Equity (as reported)44,360
Total Stockholder Equity (calculated)44,360
+/-0
Other
Capital Stock55
Cash and Short Term Investments 44,365
Common Stock Shares Outstanding 55,058
Liabilities and Stockholders Equity 60,804
Net Debt -35,221
Net Invested Capital 44,360
Net Working Capital 38,620
Property Plant and Equipment Gross 12,260
Short Long Term Debt Total 9,144



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-31
> Total Assets 
17,896
0
0
0
14,325
12,824
31,057
28,830
26,314
28,574
27,948
54,124
49,821
44,798
39,529
32,726
70,640
63,452
57,033
48,702
41,915
31,841
58,382
49,695
41,293
80,557
80,039
67,148
54,249
39,534
40,597
87,570
77,877
70,221
74,757
65,945
60,804
60,80465,94574,75770,22177,87787,57040,59739,53454,24967,14880,03980,55741,29349,69558,38231,84141,91548,70257,03363,45270,64032,72639,52944,79849,82154,12427,94828,57426,31428,83031,05712,82414,32500017,896
   > Total Current Assets 
7,031
0
0
0
3,997
2,645
21,046
19,007
16,663
19,113
16,116
42,553
38,481
33,743
28,660
22,116
60,362
53,351
44,550
35,935
26,403
16,431
38,672
30,334
22,339
61,976
61,755
49,210
36,630
22,163
23,739
71,161
62,147
54,947
59,958
51,623
45,328
45,32851,62359,95854,94762,14771,16123,73922,16336,63049,21061,75561,97622,33930,33438,67216,43126,40335,93544,55053,35160,36222,11628,66033,74338,48142,55316,11619,11316,66319,00721,0462,6453,9970007,031
       Cash And Cash Equivalents 
7,009
0
0
0
3,606
2,105
20,214
4,628
2,089
2,751
1,990
32,423
3,386
10,667
6,794
6,331
51,103
8,536
10,780
9,570
6,899
7,864
37,765
7,070
12,463
59,883
47,426
41,991
28,614
12,676
14,798
69,162
61,139
54,098
58,747
50,386
44,365
44,36550,38658,74754,09861,13969,16214,79812,67628,61441,99147,42659,88312,4637,07037,7657,8646,8999,57010,7808,53651,1036,3316,79410,6673,38632,4231,9902,7512,0894,62820,2142,1053,6060007,009
       Short-term Investments 
0
0
0
0
14,306
0
495
14,085
14,306
16,109
13,409
9,618
34,683
22,708
20,705
14,690
8,480
44,265
31,862
24,928
18,499
8,022
0
22,516
8,012
8,012
0
0
0
0
0
0
0
0
0
0
0
000000000008,0128,01222,51608,02218,49924,92831,86244,2658,48014,69020,70522,70834,6839,61813,40916,10914,30614,085495014,3060000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,371
72
61
21
8
5
0
365
0
0
0
0003650582161728,37100000000000000000000000000
       Other Current Assets 
22
0
0
0
44
47
337
294
268
253
717
512
412
368
1,161
1,095
779
550
1,908
1,437
1,005
545
907
748
1,864
958
3,267
2,866
2,131
1,979
1,062
1,244
1,008
849
1,211
1,237
963
9631,2371,2118491,0081,2441,0621,9792,1312,8663,2679581,8647489075451,0051,4371,9085507791,0951,161368412512717253268294337474400022
   > Long-term Assets 
0
0
0
0
10,328
10,179
10,011
9,823
9,651
9,461
11,832
11,571
11,340
11,055
10,869
10,610
10,278
10,101
12,483
12,767
15,512
15,410
19,710
19,361
18,954
18,581
18,284
17,938
17,619
17,371
16,858
16,409
15,730
15,274
14,799
14,322
15,476
15,47614,32214,79915,27415,73016,40916,85817,37117,61917,93818,28418,58118,95419,36119,71015,41015,51212,76712,48310,10110,27810,61010,86911,05511,34011,57111,8329,4619,6519,82310,01110,17910,3280000
       Property Plant Equipment 
190
0
0
0
329
346
344
323
317
293
2,730
2,635
2,570
2,451
2,432
2,339
2,173
2,056
3,167
3,618
7,680
7,676
12,340
12,157
11,916
11,710
11,579
11,400
11,247
11,165
10,819
10,536
10,023
9,734
9,425
9,114
8,784
8,7849,1149,4259,73410,02310,53610,81911,16511,24711,40011,57911,71011,91612,15712,3407,6767,6803,6183,1672,0562,1732,3392,4322,4512,5702,6352,730293317323344346329000190
       Goodwill 
2,791
0
0
0
2,791
2,791
2,791
2,791
2,791
2,791
2,791
2,791
2,791
2,791
2,791
2,791
2,791
2,791
2,791
2,791
2,791
2,791
2,791
2,791
2,791
2,791
2,791
2,791
2,791
2,791
2,791
2,791
2,791
2,791
2,791
2,791
2,791
2,7912,7912,7912,7912,7912,7912,7912,7912,7912,7912,7912,7912,7912,7912,7912,7912,7912,7912,7912,7912,7912,7912,7912,7912,7912,7912,7912,7912,7912,7912,7912,7912,7910002,791
       Intangible Assets 
10,665
0
0
0
7,208
7,042
6,876
6,709
6,543
6,377
6,210
6,044
5,878
5,712
5,545
5,379
5,213
5,046
4,880
4,713
4,547
4,381
4,214
4,048
3,882
3,715
3,549
3,382
3,216
3,050
2,883
2,717
2,551
2,384
2,218
2,052
1,886
1,8862,0522,2182,3842,5512,7172,8833,0503,2163,3823,5493,7153,8824,0484,2144,3814,5474,7134,8805,0465,2135,3795,5455,7125,8786,0446,2106,3776,5436,7096,8767,0427,20800010,665
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
101
101
101
101
101
101
101
208
1,645
1,645
494
562
365
365
365
365
365
365
365
365
365
365
365
365
365
365
-1,521
-1,5213653653653653653653653653653653653653653655624941,6451,6452081011011011011011011010000000000
> Total Liabilities 
1,822
0
0
0
660
650
590
967
1,016
1,242
3,788
4,189
3,826
3,703
4,482
4,652
4,306
4,338
7,172
7,721
11,178
10,073
16,054
16,991
18,399
60,160
20,289
19,761
18,559
18,738
17,182
81,381
80,125
80,889
14,257
13,800
16,444
16,44413,80014,25780,88980,12581,38117,18218,73818,55919,76120,28960,16018,39916,99116,05410,07311,1787,7217,1724,3384,3064,6524,4823,7033,8264,1893,7881,2421,0169675906506600001,822
   > Total Current Liabilities 
165
0
0
0
660
650
590
967
1,016
1,242
1,972
2,474
2,213
2,191
3,072
3,348
3,108
3,115
3,448
4,047
4,459
3,383
4,890
6,000
7,585
8,528
9,844
9,519
8,519
8,905
7,564
6,998
5,981
6,991
5,613
5,432
6,708
6,7085,4325,6136,9915,9816,9987,5648,9058,5199,5199,8448,5287,5856,0004,8903,3834,4594,0473,4483,1153,1083,3483,0722,1912,2132,4741,9721,2421,016967590650660000165
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
396
168
177
0
98
278
457
542
747
2,449
1,835
1,210
799
827
956
1,813
1,736
975
1,016
1,058
1,0581,0169751,7361,8139568277991,2101,8352,44974754245727898017716839600000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
396
0
0
0
0
0
0
0
118
1,730
1,086
436
0
0
98
917
801
0
0
0
00080191798004361,0861,730118000000039600000000000000000
       Accounts payable 
33
0
0
0
262
296
333
446
265
782
851
914
782
944
1,502
1,281
1,272
1,200
1,577
1,816
1,963
1,214
1,489
1,432
1,717
2,164
2,823
2,706
2,904
3,486
1,948
2,022
1,573
2,160
1,794
1,412
1,836
1,8361,4121,7942,1601,5732,0221,9483,4862,9042,7062,8232,1641,7171,4321,4891,2141,9631,8161,5771,2001,2721,2811,50294478291485178226544633329626200033
       Other Current Liabilities 
132
0
0
0
398
354
257
521
751
460
1,121
1,560
1,431
1,247
1,570
2,067
1,836
396
1,703
2,054
2,496
2,071
3,123
4,111
5,326
5,617
4,572
4,971
4,389
4,604
4,757
3,982
2,595
3,091
2,844
3,004
3,814
3,8143,0042,8443,0912,5953,9824,7574,6044,3894,9714,5725,6175,3264,1113,1232,0712,4962,0541,7033961,8362,0671,5701,2471,4311,5601,121460751521257354398000132
   > Long-term Liabilities 
0
0
0
0
262
296
333
446
265
782
1,816
1,715
1,613
1,512
1,410
1,304
1,198
1,223
3,724
3,674
6,719
6,690
11,164
10,991
10,814
51,632
10,445
10,242
10,040
9,833
9,618
74,383
74,144
73,898
8,644
8,368
9,736
9,7368,3688,64473,89874,14474,3839,6189,83310,04010,24210,44551,63210,81410,99111,1646,6906,7193,6743,7241,2231,1981,3041,4101,5121,6131,7151,8167822654463332962620000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
41,000
0
0
0
0
0
0
0
0
0
0
0
0000000000041,0000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,223
3,724
3,674
6,719
6,690
11,164
10,991
10,814
10,514
8,715
9,156
9,604
9,833
9,618
9,285
8,227
8,097
8,644
8,368
8,086
8,0868,3688,6448,0978,2279,2859,6189,8339,6049,1568,71510,51410,81410,99111,1646,6906,7193,6743,7241,22300000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,223
0
3,674
6,719
6,690
11,164
10,991
10,814
10,632
10,445
10,242
0
0
0
74,383
0
0
0
0
0
0000074,38300010,24210,44510,63210,81410,99111,1646,6906,7193,67401,22300000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
1,816
1,715
1,613
1,512
1,410
1,304
1,198
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000001,1981,3041,4101,5121,6131,7151,8160000000000
> Total Stockholder Equity
16,074
0
0
0
13,665
12,174
30,467
27,863
25,298
27,332
24,160
49,935
45,995
41,095
35,047
28,074
66,334
59,114
49,861
40,981
30,737
21,768
42,328
32,704
22,894
20,397
59,750
47,387
35,690
20,796
23,415
6,189
-2,248
-10,668
60,500
52,145
44,360
44,36052,14560,500-10,668-2,2486,18923,41520,79635,69047,38759,75020,39722,89432,70442,32821,76830,73740,98149,86159,11466,33428,07435,04741,09545,99549,93524,16027,33225,29827,86330,46712,17413,66500016,074
   Common Stock
8
0
0
0
8
8
13
13
13
43,145
46,150
16
84,219
17
17
17
142,053
144,908
21
21
21
21
25
25
25
26
29
29
29
29
37
37
37
37
55
55
55
55555537373737292929292625252521212121144,908142,05317171784,2191646,15043,145131313880008
   Retained Earnings Total Equity00-314,416-304,5060-285,508000-220,784-206,502-191,179-172,540-158,790-145,894-134,561-122,689-108,90100-75,718-66,765-56,004-46,841-38,173-29,470-21,984-15,804-12,606-9,797-7,030-4,77200000
   Accumulated Other Comprehensive Income 
0
0
0
0
-57
-79
-103
-8
-7
-9
-6
-2
-51
-3
-790
-3
-1
2
22
8
4
17
-1,699
1
-1
-1
0
0
0
0
0
0
0
0
0
0
0
00000000000-1-11-1,6991748222-1-3-790-3-51-2-6-9-7-8-103-79-570000
   Capital Surplus 
0
0
0
0
0
16,938
37,484
37,655
37,898
43,131
46,135
79,391
84,202
87,922
91,034
94,825
142,032
144,887
146,973
149,853
153,401
156,291
188,197
191,468
195,410
211,550
266,223
268,142
0
0
0
291,660
0
293,801
374,861
0
0
00374,861293,8010291,660000268,142266,223211,550195,410191,468188,197156,291153,401149,853146,973144,887142,03294,82591,03487,92284,20279,39146,13543,13137,89837,65537,48416,93800000
   Treasury Stock0000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
16,746
16,938
37,484
37,655
37,898
43,131
46,135
79,391
84,202
87,922
91,034
94,825
142,032
144,887
146,973
149,853
153,401
156,291
188,197
191,468
195,410
211,550
266,223
268,142
271,861
274,240
290,847
291,660
292,420
293,801
374,861
377,072
381,220
381,220377,072374,861293,801292,420291,660290,847274,240271,861268,142266,223211,550195,410191,468188,197156,291153,401149,853146,973144,887142,03294,82591,03487,92284,20279,39146,13543,13137,89837,65537,48416,93816,7460000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue-9
Cost of Revenue-1,207
Gross Profit-1,207-1,216
 
Operating Income (+$)
Gross Profit-1,207
Operating Expense-42,367
Operating Income-43,574-43,574
 
Operating Expense (+$)
Research Development27,797
Selling General Administrative15,777
Selling And Marketing Expenses1,207
Operating Expense42,36744,781
 
Net Interest Income (+$)
Interest Income0
Interest Expense-1,364
Other Finance Cost-1,676
Net Interest Income312
 
Pretax Income (+$)
Operating Income-43,574
Net Interest Income312
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-42,210-44,938
EBIT - interestExpense = -44,938
-42,210
-40,846
Interest Expense1,364
Earnings Before Interest and Taxes (EBIT)-43,574-40,846
Earnings Before Interest and Taxes (EBITDA)-42,367
 
After tax Income (+$)
Income Before Tax-42,210
Tax Provision-0
Net Income From Continuing Ops-39,474-42,210
Net Income-42,210
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses43,574
Total Other Income/Expenses Net1,364-312
 

Technical Analysis of Pulse Biosciences Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Pulse Biosciences Inc. The general trend of Pulse Biosciences Inc is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Pulse Biosciences Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Pulse Biosciences Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 7.77 < 7.79 < 7.79.

The bearish price targets are: 6.94 > 6.69 > 4.7.

Tweet this
Pulse Biosciences Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Pulse Biosciences Inc. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Pulse Biosciences Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Pulse Biosciences Inc. The current macd is -0.48340099.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Pulse Biosciences Inc price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Pulse Biosciences Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Pulse Biosciences Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Pulse Biosciences Inc Daily Moving Average Convergence/Divergence (MACD) ChartPulse Biosciences Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Pulse Biosciences Inc. The current adx is 19.53.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Pulse Biosciences Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Pulse Biosciences Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Pulse Biosciences Inc. The current sar is 6.80955303.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Pulse Biosciences Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Pulse Biosciences Inc. The current rsi is 35.42. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Pulse Biosciences Inc Daily Relative Strength Index (RSI) ChartPulse Biosciences Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Pulse Biosciences Inc. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Pulse Biosciences Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Pulse Biosciences Inc Daily Stochastic Oscillator ChartPulse Biosciences Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Pulse Biosciences Inc. The current cci is -96.44727458.

Pulse Biosciences Inc Daily Commodity Channel Index (CCI) ChartPulse Biosciences Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Pulse Biosciences Inc. The current cmo is -34.84125085.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Pulse Biosciences Inc Daily Chande Momentum Oscillator (CMO) ChartPulse Biosciences Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Pulse Biosciences Inc. The current willr is -75.33080047.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Pulse Biosciences Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Pulse Biosciences Inc Daily Williams %R ChartPulse Biosciences Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Pulse Biosciences Inc.

Pulse Biosciences Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Pulse Biosciences Inc. The current atr is 0.62641074.

Pulse Biosciences Inc Daily Average True Range (ATR) ChartPulse Biosciences Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Pulse Biosciences Inc. The current obv is -1,562,923.

Pulse Biosciences Inc Daily On-Balance Volume (OBV) ChartPulse Biosciences Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Pulse Biosciences Inc. The current mfi is 35.78.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Pulse Biosciences Inc Daily Money Flow Index (MFI) ChartPulse Biosciences Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Pulse Biosciences Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-20RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-22WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-31MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-02CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-27ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-25BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Pulse Biosciences Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Pulse Biosciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5035.424
Ma 20Greater thanMa 507.811
Ma 50Greater thanMa 1008.854
Ma 100Greater thanMa 2009.231
OpenGreater thanClose7.260
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Pulse Biosciences Inc with someone you think should read this too:
  • Are you bullish or bearish on Pulse Biosciences Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Pulse Biosciences Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Pulse Biosciences Inc

I send you an email if I find something interesting about Pulse Biosciences Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Pulse Biosciences Inc.

Receive notifications about Pulse Biosciences Inc in your mailbox!